
METHODS FOR EVALUATING VACCINE EFFICACY
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean, Yang Yang, M Halloran
2015 – 2020
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean, Yang Yang, M Halloran
2015 – 2020
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean
2018 – 2023
National Institutes of Health, National Institute of General Medical Sciences
People: Natalie Dean, Katia Koelle, Molly Gallagher, John Drake, Ana Pastore y Piontti, Laura Matrajt, Yang Yang, M Halloran, Eben Kenah, Diana Rojas Alvarez, Pejman Rohani, Aaron King
2014 – 2020
Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)
Dean NE. (2019). RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN". American journal of epidemiology, 188(4)
Dean NE, Halloran ME, Longini IM. (2018). DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. The annals of applied statistics, 12(1)
Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)
MIDAS Coordination Center
University of Pittsburgh
A737 Public Health
130 DeSoto Street
Pittsburgh PA 15261